May/June 2009

Promising Developments in Drug Delivery

Robert L. Avery, MD, and Allen C. Ho, MD

Gene Vector Delivery Platform Targets Retinal Diseases

The LentiVector technology delivers genes into retinal cells efficiently and stably.

Jennifer Kreatsoulas, PhD, News & Contributing Editor

RETINAWS: An Instructional Course in Vitrectomy Surgery

Kourous A. Rezaei, MD

Medical Udpate

A summary of general medicine news that affects your patients, your practice, and you.

Section Editor: David Boyer, MD

The Path to Intravitreal Bevacizumab

A logical decision based on scientific facts and clinical intuition.

Philip J. Rosenfeld, MD, PhD

Applying To Vitreoretinal Surgery Fellowship

Advice from recent candidates.

/with contributions from Paul Baker, MD; Leon Charkoudian, MD; Vivek Chaturvedi, MD; and Hani Salehi-Had, MD

Opportunities and Challenges for ASCs in 2009

Ophthalmologists will benefit by getting involved as the Medicare landscape evolves.

Michael Romansky

Retinal Endoscopy, Illumination, and Photocoagulation

The endoscope allows visualization and treatment of structures that would otherwise remain hidden.

Jorge G. Arroyo, MD, MPH; Taiga Kinoshita, MD; and Kyle D. Kovacs

The Role of Steroids in the Treatment of Diabetic Macular Edema

Multiple pharmacologic strategies are currently available.

Paolo Lanzetta, MD, and Daniele Veritti, MD

Recent Advances in Back of the Eye Drug Delivery

An overview of what is new in research and development.

Rad Tzekov MD, PhD; Mark B. Abelson MD, CM, FRCSC; and Daniel Dewey-Mattia

Dexamethasone Implant for DME

The Posurdex device has shown safety and efficacy in phase 2 and 2b studies to date.

Baruch D. Kuppermann, MD, PhD

Pharmacokinetics of Sustained-delivery Fluocinolone Acetonide for DME

The Iluvien retinal insert provides sustained delivery for 1 year.

Reviewed by Peter A. Campochiaro, MD

Transporter-targeted Drug Delivery to the Retina

Sudharshan Hariharan; Nilay R. Thakkar; and Ashim K. Mitra, PhD

Nanotechnology in Retinal Diseases

Several promising areas under study, including drug and gene delivery.

Marco A. Zarbin, MD, PhD, FACS

Advances in Chemotherapy for Retinoblastoma

Super-selective intraarterial infusion has proved successful with few complications.

David H. Abramson, MD, FACS

Imaging for Diabetic Macular Edema

An overview of the retina module of the Heidelberg Retina Tomograph 3.

Kemeni E. Tenku, BS; Malik Y. Kahook, MD; Cullen Barnett COT, CRA; Naresh Mandava, MD; and Scott C. N. Oliver, MD

Managing the New Logistics of Retinal Therapy

In an ongoing series, a practitioner explains how his practice manages the increase in patient volume brought on by intravitreal injections.

W. Sanderson Grizzard, MD, Partner, Retina Associates of Florida

Innovations

5 Questions With Tarek S. Hassan, MD

Dr. Hassan is a vitreoretinal physician at Associated Retinal Consultants in Royal Oak, Michigan, and a Clinical Assistant Professor of Biomedical Sciences at Oakland University in Rochester, Michigan.